Free Trial
OTCMKTS:GNGBY

Getinge AB (publ) (GNGBY) Stock Price, News & Analysis

Getinge AB (publ) logo
$18.03 +0.82 (+4.76%)
As of 01/21/2025 03:58 PM Eastern

About Getinge AB (publ) Stock (OTCMKTS:GNGBY)

Key Stats

Today's Range
$17.74
$18.03
50-Day Range
$14.91
$18.03
52-Week Range
$14.84
$22.85
Volume
121,919 shs
Average Volume
72,212 shs
Market Capitalization
N/A
P/E Ratio
30.56
Dividend Yield
1.33%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Receive GNGBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Getinge AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

GNGBY Stock News Headlines

Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Getinge price target lowered to SEK 180 from SEK 190 at JPMorgan
Kepler Capital Reaffirms Their Hold Rating on Getinge (0GZV)
See More Headlines

GNGBY Stock Analysis - Frequently Asked Questions

Getinge AB (publ)'s stock was trading at $16.3850 at the start of the year. Since then, GNGBY stock has increased by 10.0% and is now trading at $18.03.
View the best growth stocks for 2025 here
.

Shares of GNGBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
1/22/2025
Next Earnings (Estimated)
1/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
OTCMKTS:GNGBY
CIK
N/A
Employees
11,386
Year Founded
N/A

Profitability

Net Income
$227.45 million
Pretax Margin
7.07%

Debt

Sales & Book Value

Annual Sales
$3.00 billion
Cash Flow
$1.67 per share
Book Value
$10.53 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.77

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

This page (OTCMKTS:GNGBY) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners